The Prime Minister affirms the commitment of the State to provide medicine

Image

The Prime Minister affirms the commitment of the State to provide medicine

The Prime Minister, Mr. Moataz Mousi Abdullah, affirmed the commitment of the State to provide medicine as one of the basic rights of the citizen and to take the necessary measures and procedures that will ensure the provision of the medicine service and flow to be within reach of the citizen at the specified price. Minister of Industry and Trade, Minister of Industry and Trade Dr. Mohammed Abozeid Mustafa, Minister of State Hatem Hassan Bakhit, and Dr. Suad Karp, Minister of State of the State of Abu Dhabi. Wara Health and Dr. Omar Mohammed Saleh, Secretary General of the Council of Ministers. The Prime Minister announced that the State will provide free emergency treatment, children under five years of age and kidney and cancer patients, stressing the right of treatment for all citizens through the umbrella of health insurance, calling on local government officials to educate citizens and encourage them to participate in health insurance to cover all the states. The Prime Minister pointed out the state's interest in settling the pharmaceutical industry according to an integrated package of programs and arrangements with specific time limits aimed at comprehensive coverage of drugs and access to a well-established and advanced pharmaceutical industry, pointing to the positive and productive relationship with the private sector. Moataz Mousi pointed to the need for coordination between the National Fund for Medical Supplies, the National Council for Drugs and Toxins and the National Health Insurance Fund as the bodies responsible for serving the drug according to the requirements of abundance, quality, validity and comprehensiveness. The Prime Minister and the accompanying delegation toured a number of drug stores and a control room for medical supplies, which stopped the remarkable development in the system of storage and storage of drugs and the use of modern technology in the management and follow-up of drugs at the center and state levels.